Sebastian Gulde

ORCID

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Venues

Cancers

EMBO molecular medicine

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Martin Grashei, Pascal Wodtke, Jason G Skinner, Sandra Sühnel, Nadine Setzer, Thomas Metzler, Sebastian Gulde, Mihyun Park, Daniela Witt, Hermine Mohr, Christian Hundshammer, Nicole Strittmatter, Natalia S Pellegata, Katja Steiger, Franz Schilling
Simultaneous magnetic resonance imaging of pH, perfusion and renal filtration using hyperpolarized 13 C-labelled Z-OMPD. Nature communications 14 (1) (2023)
Daniela Modena, Maria Luisa Moras, Giovanni Sandrone, Andrea Stevenazzi, Barbara Vergani, Pooja Dasgupta, Andrea Kliewer, Sebastian Gulde, Alessandro Marangelo, Mathias Schillmaier, Raul Miguel Luque, Stephen Bäuerle, Natalia S Pellegata, Stefan Schulz, Christian Steinkühler
Identification of a Novel SSTR3 Full Agonist for the Treatment of Nonfunctioning Pituitary Adenomas. Cancers 15 (13) (2023)
Ninelia Minaskan Karabid, Tobias Wiedemann, Sebastian Gulde, Hermine Mohr, Renu Chandra Segaran, Julia Geppert, Maria Rohm, Giovanni Vitale, Germano Gaudenzi, Alessandra Dicitore, Donna Pauler Ankerst, Yiyao Chen, Rickmer Braren, Georgios A Kaissis, Franz Schilling, Mathias Schillmaier, Graeme Eisenhofer, Stephan Herzig, Federico Roncaroli, Jürgen B Honegger, Natalia S Pellegata
Angpt2/Tie2 autostimulatory loop controls tumorigenesis. EMBO molecular medicine 14 (5) (2022)
Sebastian Gulde, Alessia Foscarini, Simon Leonhard April-Monn, Edoardo Genio, Alessandro Marangelo, Swapna Satam, Daniel Helbling, Massimo Falconi, Rodrigo A Toledo, Jörg Schrader, Aurel Perren, Ilaria Marinoni, Natalia S Pellegata
Combined Targeting of Pathogenetic Mechanisms in Pancreatic Neuroendocrine Tumors Elicits Synergistic Antitumor Effects. Cancers 14 (22) (2022)
Sebastian Gulde, Tobias Wiedemann, Mathias Schillmaier, Isabel Valença, Amelie Lupp, Katja Steiger, Hsi-Yu Yen, Stephen Bäuerle, Johannes Notni, Raul Miguel Luque, Herbert Schmid, Stefan Schulz, Donna P Ankerst, Franz Schilling, Natalia S Pellegata
Gender-Specific Efficacy Revealed by Head-to-Head Comparison of Pasireotide and Octreotide in a Representative In Vivo Model of Nonfunctioning Pituitary Tumors. Cancers 13 (12) (2021)

Sebastian Gulde.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sebastian Gulde